Ekso Bionics Holdings

CHRN · NASDAQ

$15.76+$0.79 (+5.28%)TodayMarket closed ·
Prev close $14.97

About CHRN

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Employees
50
Headquarters
San Rafael California, California
Listed
Apr 10, 2013
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Ekso Bionics Holdings executives
NameTitleSince
Scott Davis—2022
Jerome Wong——
Jason Jones——
Mary Cloyd——
Corinna Lathan——
Charles Li——
Deborah Scher——
Stephen Kilmer—2025

Similar companies

Companies in the same industry as Ekso Bionics Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.